US2006099698A1PendingUtilityA1
Glucose dehydrogenases
Est. expiryApr 8, 2019(expired)· nominal 20-yr term from priority
Inventors:Koji Sode
C12Y 101/05002C12Y 101/03004C12Q 1/006C12Q 1/34C12N 9/0006
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Modified water-soluble glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme are provided wherein at least one amino acid residue is replaced by another amino acid residue in a specific region. Modified water-soluble PQQGDHs of the present invention have improved thermal stability.
Claims
exact text as granted — not AI-modified1 . A modified glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme wherein an amino acid residue corresponding to serine 231 in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus is replaced by another amino acid residue.
2 . A modified glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme wherein an amino acid residue corresponding to glutamine 209 in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus is replaced by another amino acid residue.
3 . A modified glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme wherein an amino acid residue corresponding to glutamate 210 in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus is replaced by another amino acid residue.
4 . A modified glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme wherein an amino acid residue corresponding to aspartate 420 in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus is replaced by another amino acid residue.
5 . A modified glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme wherein an amino acid residue corresponding to alanine 421 in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus is replaced by another amino acid residue.
6 . A modified glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme wherein at least one amino acid residue is replaced by another amino acid residue in one or more regions selected from the group consisting of the regions defined by residues 48-53, 60-62, 69-71, 79-82, 91-101, 110-115, 127-135, 147-150, 161-169, 177-179, 186-221, 227-244, 250-255, 261-263, 271-275, 282-343, 349-377, 382-393, 400-403, 412-421, 427-432, 438-441 and 449-468 in the amino acid sequence shown as SEQ ID NO: 1, characterized in that it has higher thermal stability than that of the water-soluble glucose dehydrogenase derived from Acinetobacter calcoaceticus.
7 . The modified glucose dehydrogenase of claim 3 wherein at least one amino acid residue is replaced by another amino acid residue in the region defined by residues 227-244 in the amino acid sequence shown as SEQ ID NO: 1.
8 . The modified glucose dehydrogenase of claim 7 wherein serine 231 in the amino acid sequence shown as SEQ ID NO: 1 is replaced by another amino acid residue.
9 . The modified glucose dehydrogenase of claim 3 wherein at least one amino acid residue is replaced by another amino acid residue in the region defined by residues 186-221 in the amino acid sequence shown as SEQ ID NO: 1.
10 . The modified glucose dehydrogenase of claim 9 wherein an amino acid residue corresponding to glutamine 209 in the amino acid sequence shown as SEQ ID NO: 1 is replaced by another amino acid residue.
11 . The modified glucose dehydrogenase of claim 9 wherein an amino acid residue corresponding to glutamate 210 in the amino acid sequence shown as SEQ ID NO: 1 is replaced by another amino acid residue.
12 . The modified glucose dehydrogenase of claim 3 wherein at least one amino acid residue is replaced by another amino acid residue in the region defined by residues 412-421 in the amino acid sequence shown as SEQ ID NO: 1.
13 . The modified glucose dehydrogenase of claim 12 wherein an amino acid residue corresponding to aspartate 420 in the amino acid sequence shown as SEQ ID NO: 1 is replaced by another amino acid residue.
14 . The modified glucose dehydrogenase of claim 12 wherein an amino acid residue corresponding to alanine 421 in the amino acid sequence shown as SEQ ID NO: 1 is replaced by another amino acid residue.
15 . A glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme comprising the sequence:
Asn Leu Asp Gly Xaa23l Ile Pro Lys Asp Asn Pro
Ser Phe Asn Gly Val Val Ser
wherein Xaa231 represents a natural amino acid residue other than Ser.
16 . A glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme comprising the sequence:
Gly Asp Gln Gly Arg Asn Gln Leu Ala Tyr Leu Phe
Leu Pro Asn Gln Ala Gln His Thr Pro Thr Gln Xaa209
Xaa210 Leu Asn Gly Lys Asp Tyr His Thr Tyr Met Gly
wherein Xaa209 and Xaa210 represent any natural amino acid residue, provided that when Xaa209 represents Gln, Xaa210 does not represent Glu.
17 . A glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme comprising the sequence:
Pro Thr Tyr Ser Thr Thr Tyr Asp Xaa420 Xaa421
wherein Xaa420 and Xaa421 represent any natural amino acid residue, provided that when Xaa420 represents Asp, Xaa421 does not represent Ala.
18 . A gene encoding the modified glucose dehydrogenase of any one of claim 1 .
19 . A vector comprising the gene of claim 18 .
20 . A transformant comprising the gene of claim 18 .
21 . The transformant of claim 20 wherein the gene is integrated into the main chromosome.
22 . A glucose assay kit comprising the modified glucose dehydrogenase of any one of claim 1 .
23 . A glucose sensor comprising the modified glucose dehydrogenase of any one of claim 1.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.